MESO FY 2014 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M-9.7% YoY

Gross Profit

$546,0002.1% margin

Operating Income

-$72M-278.6% margin

Net Income

-$81M-311.6% margin

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$120M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$899M

Total Liabilities

$328M

Stockholders' Equity

$572M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$29M	-9.7%
Gross Profit	$546,000	$8M	-92.7%
Operating Income	-$72M	-$60M	-20.5%
Net Income	-$81M	-$62M	-31.3%